Author

Robert Alan Beardsley

Galera Therapeutics, Inc. (United States)ORCID 0000-0002-5129-3910Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Brock J. SishciD· 1 shared D. SahaiD· 1 shared David Adam BloomiD· 1 shared Deepti B. Ramnarain· 1 shared Dennis P. RileyiD· 1 shared Elizabeth M. AlvesiD· 1 shared Jeffrey L. Keene· 1 shared Kelly L. HughesiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Brock J. SishcORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Avasopasem Manganese acts as both a Radioprotector and a Radiomitigator of Radiation-Induced Acute or Late Effects.

Brock J. Sishc, Deepti B. Ramnarain, Zeng‐Fu Shang, Elizabeth M. Alves, David Adam Bloom, Kelly L. Hughes, D. Saha, Dennis P. Riley, Jeffrey L. Keene, Robert Alan Beardsley, Michael D. Story

This paper demonstrates that Avasopasem Manganese reduces radiation-induced acute and late effects in normal tissues but does not protect tumor cells.

Frontiers in Oncology · Feb 20, 2026Peer-reviewedCancer Biology